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Objective. The Geriatric Depression Scale (GDS) is an evaluation tool to diagnose older adult’s depression. This questionnaire was
defined by Yesavage and Brink in 1982; it was designed expressly for the older person and defines his/her degree of satisfaction,
quality of life, and feelings. The objective of this study is to evaluate the psychometric properties of the Italian translation of the
Geriatric Depression Scale (GDS-IT).Methods.The Italian version of the Geriatric Depression Scale was administered to 119 people
(79 people with a depression diagnosis and 40 healthy ones). We examined the following psychometric characteristics: internal
consistency reliability, test-retest reliability, concurrent validity, and construct validity (factor structure). Results. Cronbach’s Alpha
for the GDS-IT administered to the depressed sample was 0.84. Test-retest reliability was 0.91 and the concurrent validity was 0.83.
The factorial analysis showed a structure of 5 factors, and the scale cut-off is between 10 and 11.Conclusion.TheGDS-IT proved to be
a reliable and valid questionnaire for the evaluation of depression in an Italian population. In the present study, the GDS-IT showed
good psychometric properties. Health professionals now have an assessment tool for the evaluation of depression symptoms in the
Italian population.
1. Introduction
The Geriatric Depression Scale (GDS) is one of the most
popular scales for the evaluation of depression symptoms in
older adults; it is composed of 30 items and excludes somatic
and psychotic symptoms. Items are scored dichotomous and
this fact makes the tool easier to use in older patients with
cognitive deficits [1]. The GDS is defined self-report and
needs an average of 20 minutes to complete. The score goes
from 0 (not depressed) to 30 (serious depression) with a cut-
off at score 11 in the original version. In the literature, there are
many studies that described the validation of the GDS either
in the original formula or the short ones with 5, 10, and 15
items.
According to a review in 2006, the average of the scale’s
sensitivity is 0.753 while the specificity’s one is 0.770, which
is considered modest but not excellent. Among the 33 studies
included in the review,most studies declare 10 (8 studies) or 11
(13 studies) as the cut-off; just two studies state a cut-off lower
than 7 [2].
The GDS-30 was validated in Chinese [3], Greek [4],
Spanish [5], Korean [6], Portuguese [7], and Singhalese [8].
It was also validated for different pathologies: adults who are
poststroke [9], in palliative care [10], who have Parkinson’s
disease [11], and who have Alzheimer’s disease [12].
In Italy, the GDS is widely used but all the psychometric
properties have not been investigated. Considering that in
Italy depression is one of the most commonmental disorders
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[13]; it seems necessary to validate an assessment tool for
the screening of depression. Therefore, the objective of the
present study is to evaluate the psychometric properties of
the Italian translation of the GDS through a cross-sectional
study.
2. Methods
After having received the confirmation for the realization
of the study from the authors of the original version and
the authorization from Professor Fabiano Cavarzeran for the
use of the Italian translation of the instrument, the research
protocolwas drafted as recommended by international guide-
lines [14]. In order to draw up the protocol, we followed
the original version that considered the validation of the
instrument on a sample of adults with depression and healthy
people.
Between November 2015 and March 2016, the sample of
individuals with a diagnosis of depression was recruited from
four clinics in the urban area of Rome. Before administering
the test, each person was informed about the study and they
signed an informed consent [15, 16]. All the participant had
to respect the following criteria: age ≥ 65, MMSE ≥ 18/30
[17], and a confirmed diagnosis of depression, according to
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition, Text Revision (DSM-IVTR) (American Psy-
chiatric Association, 2000). The inclusion criteria for the
health group were age ≥ 65, MMSE ≥ 18/30 [17].
For the test-retest reliability, 30 people with depression
diagnoses were randomly selected from the study sample.
The GDS-IT was administered twice at a maximum distance
of 6 days. For a significant statistical value, the scale was
considered stable for ICC > 0.70. The internal consistency of
the GDS-IT was examined by Cronbach’s Alpha in order to
assess the correlation of the item and the homogeneity of the
scale. The limit was set a 0.60. To determine the concurrent
validity, we compared the obtained score on the GDS-IT to a
diagnosis of depression according to DSM-IV TR.
The appropriateness of sampling was evaluated using the
Keiser-Meyer-Olkin (KMO) and Bartlet test. The factorial
structure of the test was determined through the analysis
of the principal components with oblique rotation and with
the maximum likelihood solution. It was made according to
Graetz’s recommendations, who states that, with the oblique
rotation, results are more convenient and provide an easily
interpreting solution.
To compare our test and depression diagnosis’ data, the
ROC curve and the area under the AUC’s one were created
and valuated. Collectively, a 1.0 AUC refers to a precise
data, while an imprecise one shows a 0.0 AUC. Usually,
an AUC higher than 0.75 shows that scale predictors are
moderate, while the excellent ones are obtained with an
AUC ≥ 0.90. The best cut-off point was chosen to give the
maximum Youden Index [18]. Two 𝑝 < 0.05 were considered
statistically significant. The agreement measure among the
register’s score and scale’s one was evaluated through the
Kappa test. The acceptability of the scale was evaluated in
terms of time, multiple entries, and compilation of mis-
prints. All the statistical analyses were carried out with the
Table 1: Characteristics of the sample.
Depression diagnosis Healthy
Sample 79 40
Age (average ± DS) 76,6 ± 8,2 74,8 ± 8,5
Sex F 𝑛 (%) 55 (69,6%) 18 (45%)
MMSE (average ± DS) 24,28 ± 3,4 26,93 ± 2,4
Sample of 145 people
119 included 
79 depression diagnosis
30 test-retest people
40 healthy people
26 excluded:
24 MMSE < 18
2 no informed consent
Figure 1: Flowchart.
statistical package of Social Sciences (SPSS), 18.0 Windows
version.
3. Results
3.1. Participants. For our study, 145 people were evaluated,
where 119 respected the criteria for the inclusion. 40 healthy
people were recruited from community setting. In Figure 1,
there is the sample of healthy and pathological people. The
characteristics of the sample can be found in Table 1.
3.2. Reliability Test (Test Retest). 30 people recruited for the
test-retest interrater showed statistically significant results for
every item with an ICC higher than 0.60 and an ICC of 0.91
for the whole scale (Table 2).
3.3. Internal Consistency and Reliability. Internal consistency
and reliability were evaluated through the correlation of Pear-
son and Cronbach’s Alpha. An item for item correlation and
total item of them (Table 3) showed statistically significant
data. Cronbach’s Alpha scored 0.839.
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Table 2: Test-retest analysis.
Item Test Retest ICC IC 95%
M (DS) M (DS)
(1) 0,53 ± 0,50 0,57 ± 0.50 0,935 (0,868–0,968]
(2) 0,50 ± 0,50 0,47 ± 0,50 0,668 (0,410–0,827]
(3) 0,53 ± 0,50 0,60 ± 0,49 0,873 (0,750–0,937]
(4) 0,70 ± 0,46 0,80 ± 0,40 0,757 (0,549–0,876]
(5) 0,73 ± 0,45 0,77 ± 0,43 0,736 (0,516–0,865]
(6) 0,73 ± 0,45 0,77 ± 0,45 0,689 (0,162–0,719]
(7) 0,57 ± 0,50 0,67 ± 0,47 0,808 (0,634–0,904]
(8) 0,33 ± 0,47 0,27 ± 0,45 0,532 (0,218–0,746]
(9) 0,57 ± 0,50 0,57 ± 0,50 0,729 (0,504–0,861]
(10) 0,67 ± 0,47 0,70 ± 0,46 0,663 (0,129–0,702]
(11) 0,80 ± 0,40 0,73 ± 0,45 0,638 (0,365–0,809]
(12) 0,50 ± 0,50 0,53 ± 0,50 0,668 (0,410–0,827]
(13) 0,43 ± 0,50 0,40 ± 0,49 0,659 (0,397–0,822]
(14) 0,33 ± 0,47 0,37 ± 0,49 0,782 [0,592–0,890]
(15) 0,20 ± 0,40 0,23 ± 0,43 0,611 [0,191–0,733]
(16) 0,60 ± 0,49 0,63 ± 0,49 0,649 [0,383–0,816]
(17) 0,47 ± 0,50 0,47 ± 0,50 0,866 [0,738–0,934]
(18) 0,30 ± 0,46 0,67 ± 0,47 0,782 [0,592–0,890]
(19) 0,40 ± 0,49 0,43 ± 0,50 0,934 [0,865–0,968]
(20) 0,63 ± 0,49 0,70 ± 0,46 0,558 [0,253–0,762]
(21) 0,47 ± 0,50 0,70 ± 0,46 0,61 [0,326–0,793]
(22) 0,30 ± 0,46 0,30 ± 0,46 0,683 [0,432–0,835]
(23) 0,43 ± 0,50 0,50 ± 0,50 0,874 [0,735–0,938]
(24) 0,70 ± 0,46 0,67 ± 0,47 0,925 [0,850–0,954]
(25) 0,600 ±,49 0,57 ± 0,50 0,934 [0,865–0,968]
(26) 0,23 ± 0,46 0,33 ± 0,47 0,609 [0,325–0,793]
(27) 0,60 ± 0,49 0,57 ± 0,50 0,659 [0,397–0,822]
(28) 0,33 ± 0,47 0,25 ± 0,47 0,691 [0,446–0,840]
(29) 0,40 ± 0,49 0,37 ± 0,49 0,932 [0,862–0,967]
(30) 0,60 ± 0,49 0,60 ± 0,49 0,861 [0,729–0,931]
Total 15,37 ± 5,46 16,17 ± 5,76 0,914 [0,828–0,958]
3.4. Factorial Analysis. The Bartlett test showed a value of
0.563 and with 𝑝 < 0.001; this shows a good suitability of
the sample. The factorial analysis produced 5 factors for the
GDS-IT that represents the 54.7% of the variance (Table 4).
The first factor is composed of 8 items (“Are you bothered
by thoughts you can’t get out of your head?” “Are you afraid
that something bad is going to happen to you?” “Do you
often feel helpless?” “Do you often get restless and fidgety?”
“Do you feel downhearted and blue?” “Do you feel that your
situation is hopeless?” “Do you frequently get upset over little
things?” “Do you frequently feel like crying?”) that contribute
to 17.89% of the total of variance. This factor is called “sad
mood and agitation.”
The second factor is composed of 7 items (“Are you
basically satisfied with your life?” “Do you feel that your life is
empty?” “Do you think it is wonderful to be alive now?” “Do
you feel pretty worthless the way you are now?” “Do you find
life very exciting?” “Do you think that most people are better
off than you are?” “Is your mind as clear as it used to be?”)
that contribute to 12.72% of the total of variance. This factor
is called “cognitive inefficiency.”
The third factor is composed of 4 items (“Have you
dropped many of your activities and interests?” “Is it hard for
you to get started on new projects?” “Do you feel full of
energy?” “Is it easy for you to make decisions?”) that con-
tribute to 9.78% of the variance. This factor is called “lack of
energy.”
The forth factor is composed of 4 items (“Are you hopeful
about the future?” “Are you in good spirits most of the time?”
“Do you feel happy most of the time?” “Do you enjoy getting
up in the morning?”) that contribute to 7.52% of the variance.
This factor is called “positive mood.”
The fifth factor is composed of 7 items (“Do you often get
bored?” “Do you prefer to stay at home, rather than going out
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Table 3: Item X tot-item analysis.
Item Corrected item-totalcorrelation
Cronbach’s Alpha if item
was deleted
Corrected item-total
correlation
Cronbach’s Alpha if item
was deleted
(1) ,104 ,791 ,597 ,809
(2) ,009 ,795 −,075 ,836
(3) ,256 ,784 ,236 ,821
(4) ,335 ,780 ,472 ,812
(5) ,445 ,775 ,173 ,823
(6) ,361 ,779 ,426 ,814
(7) ,469 ,773 ,180 ,822
(8) ,469 ,773 ,331 ,818
(9) ,325 ,780 ,457 ,813
(10) ,517 ,771 ,257 ,820
(11) ,399 ,777 ,683 ,801
(12) ,183 ,787 ,090 ,827
(13) ,203 ,786 ,530 ,809
(14) ,289 ,782 ,395 ,817
(15) ,258 ,783 ,000 ,824
(16) ,594 ,767 ,409 ,815
(17) ,271 ,783 ,568 ,812
(18) ,171 ,787 ,597 ,806
(19) ,129 ,789 ,506 ,812
(20) ,295 ,782 ,481 ,811
(21) ,212 ,785 ,182 ,824
(22) ,443 ,775 ,451 ,816
(23) ,443 ,775 ,196 ,821
(24) ,480 ,773 ,474 ,811
(25) ,440 ,775 ,318 ,818
(26) ,305 ,781 ,120 ,825
(27) ,140 ,789 ,250 ,820
(28) −,065 ,796 ,491 ,813
(29) ,365 ,778 ,020 ,830
(30) ,004 ,794 ,318 ,818
and doing new things?” “Do you frequently worry about the
future?” “Do you feel you have more problems with memory
than most?” “Do you worry a lot about the past?” “Do you
have trouble concentrating?” “Do you prefer to avoid social
gatherings?”) that contribute to 6.76% of the variance. This
factor is called “social withdrawal.”
3.5. Prognosis. Regarding the evaluation of patients with
depression, the area under the curve (AUC) showed a value of
0.901 (CI 0.739–0.811 95%) (Figure 2). The maximized score
that predicts depression is between 10/11 (sensitivity, 84%;
specificity, 77.5%).
The Kappa test, for the agreement between the measure
of the scale and the register for limitations from manual
handling of loads, showed an agreement of 0.42 with 𝑝 <
0.0001.
3.6. Acceptability. The average of compilation was 10.6 ± 3.3
minutes in the first revelation (2–13 range) and 9.7±2.9 in the
second one (2–12 range). There were no double reactions or
misprints.
4. Discussion
The depression is a pathology that respects specific criteria
to make a diagnosis but the evaluation and the resolution of
problems correlated to that pathology are not so easy as well.
The GDS-30 has been used and in previous two Italian
studies in Alzheimer disease, it has not undergone a valida-
tion process yet [19, 20].
The objective of this studywas to verify that theGDS-30 is
a valid tool that can be used to evaluate the psychoemotional
status of patients with depression.
The validation process of the Italian translation of the
Geriatric Depression Scale (GDS-IT) showed statistically sig-
nificant data regarding the reliability and internal consistency
of the GDS-IT. Thus, all of the items are correlated and
Cronbach’s Alpha has a value of 0.839, in line with the
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Table 4: Factorial analysis.
Factor
1 2 3 4 5
(1) Are you basically satisfied with your life? 0,62
(2) Have you dropped many of your activities and interests? 0,63
(3) Do you feel that your life is empty? 0,51
(4) Do you often get bored? 0,53
(5) Are you hopeful about the future? 0,56
(6) Are you bothered by thoughts you can’t get out of your head? 0,57
(7) Are you in good spirits most of the time? 0,6
(8) Are you afraid that something bad is going to happen to you? 0,75
(9) Do you feel happy most of the time? 0,70
(10) Do you often feel helpless? 0,69
(11) Do you often get restless and fidgety? 0,65
(12) Do you prefer to stay at home, rather than going out and doing new things? 0,41
(13) Do you frequently worry about the future? 0,38
(14) Do you feel you have more problems with memory than most? 0,64
(15) Do you think it is wonderful to be alive now? 0,36
(16) Do you feel downhearted and blue? 0,78
(17) Do you feel pretty worthless the way you are now? 0,86
(18) Do you worry a lot about the past? 0,62
(19) Do you find life very exciting? 0,78
(20) Is it hard for you to get started on new projects? 0,63
(21) Do you feel full of energy? 0,53
(22) Do you feel that your situation is hopeless? 0,61
(23) Do you think that most people are better off than you are? 0,52
(24) Do you frequently get upset over little things? 0,63
(25) Do you frequently feel like crying? 0,67
(26) Do you have trouble concentrating? 0,34
(27) Do you enjoy getting up in the morning? 0,51
(28) Do you prefer to avoid social gatherings? 0,31
(29) Is it easy for you to make decisions? 0,65
(30) Is your mind as clear as it used to be? 0,25
Percent of variance% 17,89 12,72 9,78 7,52 6,76
Spanish version [5], but slower lighter than Portuguese [7]
and original [1] validation studies. This data shows that the
scale results are reliable and have a good internal consistency.
In the study, the cut-off score of the GDS-IT in patients
with depression is 10/11, with sensitivity at the 84%, and a
specificity at the 77.5%.This data is consistentwith the English
(cut-off 10/11), Portuguese (cut-off 11), and Spanish (cut-off
9/10) studies and with most of the studies of validation of the
Geriatric Depression Scale [2].
The GDS-IT factorial analysis showed a structure with 5
factors almost similar to the structure of the original version
[21]. The original version is composed of 5 factors: sad mood
(8, 6, 23, 13, 15, 18, 10, 24, 22), lack of energy (29, 20, 21, 30,
25, 2), positive mood (15, 27, 9, 5, 7, 19), agitation (24, 11, 4),
and social withdrawal (12, 28). From the original version 4
items stayed out. The factorial analysis that we obtained is
also similar to the Korean version of the Geriatric Depression
Scale. This one is composed of 5 factors: sad mood and
agitation (6, 18, 11, 8, 13, 24, 16, 25, 10, 3), positive mood (1,
9, 7, 15, 19, 22, 27, 5, 23), lack of energy (2, 21, 20, 17), cognitive
inefficiency (14, 26, 30), and social withdrawal (12, 28)
[6].
In the English version, 4 items do fall under any factor
and they are 1, 3, 14, and 17. In the GDS-IT, items “Are you
basically satisfied with your life?” “Do you feel that your life is
empty?” “Do you feel pretty worthless the way you are now?”
are included in factor 2, while the item “Do you feel you
have more problems with memory than most?” is included
in factor 5.
In the Korean version, item 29 was excluded by the
factorial analysis that in the GDS-IT is in factor 3. Differences
between the factorial analysis of the mentioned versions
(English and Korean) could be cultural and attributed to
samples of study among the various validations.
6 Depression Research and Treatment
0.000
0.200
0.400
0.600
0.800
1.000
Se
ns
iti
vi
ty
0.200 0.400 0.600 0.800 1.0000.000
1 − specificity
Figure 2: ROC curve. Diagonal segments are produced by ties.
At the end of the study, the GDS-IT revealed itself as
easy to use and understand and, according to the obtained
results, has been shown to be valid and reliable tool in Italian
population and is recommended for use in clinical practice.
However, to better understand the complexity of the target
population, a clinical investigation in the most common
principal diagnoses of the elderly people with a larger sample
size is required.
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